For more than a decade, CAR-T cell therapy has been one of the biggest breakthroughs in cancer medicine. By reprogramming a ...
Response rates to second-line STS therapies, including pazopanib, are typically <10% with median PFS <5 months, underscoring demand for predictive biomarkers. Transcriptomic profiling of 11 paired pre ...
Year-to-Date Operating Expense Reduction: Total operating expenses for the six months ended June 30, 2026 decreased by $14.3 million compared to the same period in 2025, reflecting a $7.5 million, 13% ...
The nucleus of the cells of interest has been labeled scarlet. Credit: University of Manchester Researchers found that a little-known group of immune cells is crucial for keeping cancer-fighting T ...
If you use a disinfectant wipe or cleaner to tackle everyday spills, experts say you may be cleaning the wrong way — and ...
For most healthy people, Cryptococcus is an unnoticed infection. The immune system walls it off in the lungs and keeps it dormant for life. But in patients undergoing cancer chemotherapy, recovering ...
The Gurugram-based company is developing allogeneic CAR-NK cell therapies made from healthy donor cells, backed by a $4.2 ...
Spread the love“`html Imagine a world where a cancer diagnosis, while still devastating, doesn’t carry the same chilling ...
Cancer can be just like the killer in a horror movie – it may seem like he's been destroyed forever by the Good Guy, but then ...
Researchers found arginine strengthened a key immune pathway that improved protection against colorectal cancer, influenza, ...
After ruling out several established immune pathways, the researchers used a genome-wide CRISPR screen to search for the ...